US Magnetic Resonance Imaging Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

US Magnetic Resonance Imaging Market Trends and Insights

Rising Global Burden of Chronic and Age-Related Diseases

Seventy-six point four percent of US adults reported at least one chronic condition in 2025, a pattern that translates into sustained MRI utilization for neurological, oncological, and cardiac evaluations. Providers favor the modality’s soft-tissue contrast to diagnose Alzheimer’s, multiple sclerosis, and ischemic stroke, where early detection improves therapeutic outcomes. FDA clearance for GE HealthCare’s head-only SIGNA MAGNUS 3.0 T platform exemplifies industry response, delivering specialized neuro-imaging in shorter sessions ^{[1]GE HealthCare, “SIGNA MAGNUS 3.0 T Neuroimaging System Receives FDA Clearance,” gehealthcare.com}. The same demographic shift accelerates oncology imaging because precision medicine protocols rely on repeat, high-resolution tumor mapping. Collectively, the chronic disease burden adds a 1.8-percentage-point lift to long-term market growth.

Increasing Reimbursement Coverage and Government Support for High-Value Imaging Modalities

CMS finalized a 5.06% rate hike for Medicare Advantage plans in 2026, releasing more than USD 25 billion in extra funding that will flow into diagnostic imaging volumes ^{[2]Centers for Medicare & Medicaid Services, “2026 Medicare Advantage Rate Announcement,” cms.gov}. Administrative relief also arrived when CMS removed the lumbar-spine MRI measure from quality reporting, easing provider workflow. Commercial payers follow suit by steering patients to cost-efficient outpatient centers, which often invest in new scanners to win network contracts. These moves collectively add 1.2-percentage-points to medium-term growth while reducing historical revenue volatility tied to fee-schedule cuts.

Technological Breakthroughs in MRI

Deep-learning reconstruction shrinks scan times by roughly 30%, lifting daily scanner capacity by as much as one-third without sacrificing image quality. Philips’ SmartSpeed Precise engine doubles this benefit by pairing two AI algorithms to enhance sharpness 80% and cut exam time by a factor of three. At the opposite end of the spectrum, 0.05 T ultra-low-field prototypes plug into standard wall power and waive RF-shielding needs, trimming install cost close to 90%. Bayer’s gadoquatrane contrast agent lowers gadolinium exposure 60%, a safety gain for renally impaired patients. Collectively, technology adds 1.5 percentage-points to CAGR as hospitals adopt AI suites and helium-free magnets.

Steady Growth in Healthcare Spending and Modernization of Hospital & Outpatient Imaging Infrastructure Worldwide

Allegheny Valley Hospital invested USD 12 million to expand its radiology suite, inserting a mobile MRI to open 40 new weekly slots. Certificate-of-need reform quickens outpatient build-outs; US Radiology Specialists plans 12 freestanding centers in 2025 to extend reach into underserved communities. Vizient projects advanced outpatient imaging to climb 13% over the next decade, a shift that supports the US MRI market trajectory. GE HealthCare’s seven-year pact with Sutter Health covers 300 facilities and integrates AI triage tools, illustrating how vendors secure long-run volume through enterprise deals.

High Cost of MRI Systems

A high-field scanner typically costs more than USD 225,000 and demands expensive site prep that includes RF shielding and cryogenic cooling ^{[3]IEEE, “Cost Barriers for Rural MRI Installations,” ieee.org}. Rural hospitals already under fiscal strain defer such purchases, contributing to more than 100 facility closures since 2010 that removed imaging access for nearly one-fifth of rural residents. Technology is starting to blunt the barrier: ultra-low-field hardware priced near USD 22,000 eliminates helium, while Philips BlueSeal magnets save 5 million liters of helium and 40 MWh of energy per system since 2018. Even as acquisition costs erode, price remains a drag of 0.8-percentage-points on long-term growth.

Shortage of Certified MRI Technologists

Vacancy rates for radiologic technologists stood at 18.1% in 2025 compared with 6.2% three years earlier ^{[4]Radiology Society of North America, “Radiologic Technologist Vacancy Survey 2025,” rsna.org}. Staffing gaps lengthen wait times and force some departments to curtail evening or weekend schedules, limiting throughput by up to 20%. Salaries climbed to a median USD 83,740, yet training capacity lags demand. Providers respond with apprenticeship programs like US Radiology Specialists’ Technologist Advancement Academy, which graduated 19 technologists and enrolled 27 trainees in 2025. AI automation lightens repetitive positioning and protocol selection, but human oversight of patient safety and quality assurance remains non-negotiable, subtracting 1.2-percentage-points from short-term growth.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Architecture: Closed Systems Dominate Despite Portable Innovation

Closed units held 77.62% of the US MRI market in 2025, confirming the modality’s reliance on full-body, high-field imaging for complex neuro and oncology cases. The canonical wide-bore 70 cm format eases patient anxiety without compromising gradient performance, a mix ideal for community hospitals that require versatility. Extremity-specific magnets cater to orthopedic clinics, yet their impact on total revenue remains modest. Portable systems contribute the fastest growth at 6.31% CAGR through 2031 as emergency departments, intensive-care units, and rural sites seek point-of-care diagnostic options. Hyperfine’s FDA-cleared Swoop employs NVIDIA AI to improve brain image quality and demonstrates a mobile install footprint the size of a ventilator cart. Open magnets retain relevance for claustrophobic or bariatric patients, though their lower field strength limits nuanced neurovascular work compared with closed 1.5 T or 3 T designs.

Portable MRI’s rise intersects with value-based care goals because bedside imaging avoids costly patient transport and lowers sedation risk. Yet reimbursement codes still favor conventional rooms, so adoption concentrates within academic centers able to fund pilots. Vendors now bundle financing and AI software to convert pilot orders into fleet rollouts, a tactic reflecting broader competition on total cost of ownership rather than sticker price. Hospitals that replace aging 1.5 T scanners often opt for helium-free magnets to hedge against commodity volatility, a choice that further cements closed architecture leadership while portable units carve new revenue streams in non-traditional settings. 

By Field Strength: Mid-Field Dominance with Ultra-High Growth

One-point-five-tesla scanners represented 47.62% of the US MRI market size for field strength in 2025, favored for balanced acquisition cost, maintenance, and clinically adequate signal-to-noise ratios. Community hospitals prefer 1.5 T because gradient upgrades and AI reconstruction now rival 3 T performance in many body and cardiac applications. Low-field magnets under 0.3 T stay relevant where metal implants or cost constraints preclude high-field use, but their share declines as portable high-performance options emerge. GE SIGNA Sprint pushes 1.5 T gradient power to 200 mT/m, blurring the historical performance gap with 3 T systems.

Ultra-high-field platforms above 7 T log a 5.98% CAGR through 2031, primarily within research hospitals that require micro-structural brain imaging or spectroscopy. FDA cleared 7 T for limited clinical use, and presurgical mapping for epilepsy benefits from submillimeter resolution that guides resection margins. However, siting a 7 T unit entails reinforced flooring and new power feeds, which caps volumes to top neurology centers. Very-high-field 3 T maintains an important niche in advanced musculoskeletal and prostate work, where higher signal-to-noise ratios permit multiparametric protocols without contrast. Investors weigh ultra-high-field revenue potential against utilization risk; therefore many choose 3 T upgrades combined with AI acceleration as an interim path toward precision imaging.

By Application: Neurology Leadership with Oncology Acceleration

Neurology retained 40.55% of the US MRI market size by application in 2025, underscoring MRI’s dominant role in stroke triage, dementia workups, and multiple sclerosis monitoring. The SIGNA MAGNUS head-only platform signals manufacturers’ commitment to neurology, where focused field homogeneity yields superior cortical detail. Cardiac applications grow steadily thanks to contrast advances such as flurpiridaz that sharpen perfusion mapping. Musculoskeletal imaging benefits from dedicated extremity coils, serving sports medicine and aging baby boomers seeking joint replacements.

Oncology commands the fastest trajectory at a 6.86% CAGR, reflecting both incidence trends and precision therapy. Abbreviated breast MRI protocols bring exam time under ten minutes, making high-risk screening feasible in busy outpatient centers. The University of Waterloo’s synthetic diffusion sequence makes malignant tissue glow, allowing surgeons to plan margins with confidence. AI drives lesion segmentation and response assessment, giving radiologists quantitative biomarkers that translate directly into clinical trial endpoints. As payers link reimbursement to outcomes, such analytics elevate MRI from anatomical snapshot to longitudinal decision platform.

Geography Analysis

The United States exhibits regional contrasts that influence scanner mix and procedure volume. Major metro areas such as New York, Los Angeles, and Chicago account for the densest concentration of 3 T and experimental 7 T installations owing to academic medical centers and higher per-capita health expenditure. CMS projects national health-spending growth of 5.6% annually through 2032, a trend that funds continued fleet renewal in these hubs. Northeast and West Coast providers execute early AI rollouts because strong capital reserves offset software subscription fees. Patients in these regions receive MRI earlier in the diagnostic chain, which raises utilization to levels that eclipse national averages.

Rural communities house nearly 20% of the population yet witnessed more than 100 hospital closures since 2010, creating imaging deserts that pressure state health agencies to subsidize point-of-care solutions. Hyperfine and other portable vendors position ultra-low-field units as bridge technology that brings neuroimaging to critical-access hospitals without infrastructure overhaul. Southern and Midwest states show mixed dynamics; urban centers invest in 3 T upgrades while farming counties struggle with staffing shortages. Regional Certificate-of-Need reform loosens restrictions, enabling outpatient developers to open imaging centers near growing suburbs, a change likely to lift regional scan volumes over the next five years.

Medicare Advantage penetration varies widely, topping 55% in Florida yet below 25% in Wyoming, which shapes reimbursement appetites for new technology. States with generous Medicaid expansion also channel demand; community hospitals in California leverage supplemental payments to finance helium-free magnets as part of decarbonization pledges. The 300-facility Sutter Health–GE pact in California illustrates how vendor-provider alliances expand AI capability statewide, while Mid-Atlantic systems pursue similar deals to counter competitive threat from regional for-profit chains. 

Regulatory Landscape

MRI systems in the United States are regulated by the US Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH). Conventional magnetic resonance diagnostic devices are generally regulated as Class II devices (21 CFR 892.1000), which commonly requires 510(k) clearance prior to commercialization. For non-substantially equivalent devices, clinical investigations can require an Investigational Device Exemption (IDE), depending on the risk determination.

Compliance expectations have also moved toward harmonized quality systems. The FDA Quality Management System Regulation (QMSR) became effective on February 2, 2026, and it incorporates ISO 13485:2016-aligned requirements, shaping OEM design controls, supplier qualification, and post-market processes. In parallel, FDA guidance on testing and labeling for safety in the MR environment continues to influence labeling, accessory compatibility, and site safety practices at hospitals and outpatient imaging centers.

Value Chain Analysis

The US MRI value chain includes upstream component suppliers for superconducting magnets, cryogenics or sealed magnet technologies, gradient and RF subsystems, coils, and electronics, followed by OEM system integration, software configuration, and quality assurance. Value capture tends to concentrate in final assembly and integration, workflow and reconstruction software, installation services (including site planning and RF shielding when required), and lifecycle service contracts that support uptime and fleet standardization for large health systems.

Sourcing dynamics remain a key differentiator, since high-field magnet assemblies and certain precision subsystems are often imported from established manufacturing bases in Europe and Japan. Distribution and service are then carried out through OEM field organizations and third-party service providers. The FDA Office of Supply Chain Resilience (OSCR) also adds an institutional anchor for medical device supply monitoring, reinforcing the strategic importance of supplier diversification, parts availability, and remote monitoring for installed-base performance.

Market Opportunities and Future Outlook

Replacement demand and modernization create a broad addressable pool for vendors and service partners, especially as providers focus on throughput and staffing efficiency alongside an 18.1% radiologic technologist vacancy rate reported in 2025. AI-enabled reconstruction and workflow automation open whitespace in mid-field and high-field upgrades (1.5 T and 3 T), where providers can increase exam capacity without adding rooms. These enterprise purchasing patterns are visible in agreements such as GE HealthCare’s seven-year pact with Sutter Health, which covers 300 facilities and reflects bundled software, service, and standardization.

Sustainability-driven choices also extend near-term opportunity across new placements and refresh cycles, including helium-free or virtually helium-free magnet designs and lower-energy operation. Recent FDA clearances and 2026 launches, such as Siemens Healthineers’ virtually helium-free MAGNETOM Flow 1.5 T platform and Philips solutions spanning AI cardiac planning and MR-enabled radiotherapy simulation, also point to product pathways that broaden MRI use beyond routine diagnostics into oncology treatment workflows and more standardized cardiac MR adoption across sites.